Is attention to detail a similarly strong candidate endophenotype for anorexia nervosa and bulimia nervosa?

被引:89
|
作者
Roberts, Marion E. [1 ]
Tchanturia, Kate [1 ]
Treasure, Janet L. [1 ]
机构
[1] Kings Coll London, Inst Psychiat, Div Psychol Med, Sect Eating Disorders, London, England
来源
关键词
Anorexia; bulimia; neuropsychology; cognition; endophenotypes; CENTRAL COHERENCE; COGNITIVE PHENOTYPE; PARENTS; AUTISM; WOMEN; SIBLINGS; CHILDREN; SCALE;
D O I
10.3109/15622975.2011.639804
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives. To investigate whether attention to detail is a similarly strong candidate endophenotype of anorexia (AN) and bulimia nervosa (BN), and to explore the incidence and clinical correlates of attention to detail. Methods. A total of 266 women (including AN, BN, recovered AN, unaffected sisters of AN/BN & control women) undertook a thorough clinical assessment and were administered two neuropsychological measures of attention to detail (Group Embedded Figure Test; Rey-Osterrieth Complex Figure). Results. Superior attention to detail was found across all AN groups including recovered AN and unaffected AN sisters. Those with BN and their unaffected sisters showed a profile more consistent with poor global integration. The combined effect of superior attention to detail and poor global integration ("weak coherence") was present in 42.3% of active cases and corresponded with a more severe illness, elevated obsessive-compulsive symptoms, and a higher likelihood of comorbid clinical anxiety and self-harm. Conclusions. Attention to detail is a stronger candidate endophenotype of AN compared to BN, where poor global integration may be more relevant. The unique contribution of both aspects of weak coherence (superior attention to detail/poor global integration) requires further exploration and understanding in both eating disorders. Integrating cognitive remediation of these traits into treatment for the subset of patients it is relevant for may improve outcome.
引用
收藏
页码:452 / 463
页数:12
相关论文
共 50 条
  • [1] Anorexia nervosa and bulimia nervosa
    Huber, M.
    NEPHROLOGE, 2018, 13 (01): : 12 - 18
  • [2] Anorexia nervosa und Bulimia nervosaAnorexia nervosa and bulimia nervosa
    M. Huber
    Der Nephrologe, 2018, 13 (1): : 12 - 18
  • [3] BULIMIA NERVOSA AND ANOREXIA-NERVOSA
    TREASURE, J
    PRACTITIONER, 1989, 233 (1479) : 1525 - 1527
  • [4] ANOREXIA-NERVOSA AND BULIMIA NERVOSA
    GOLDBLOOM, DS
    KENNEDY, SH
    KAPLAN, AS
    WOODSIDE, DB
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1989, 140 (10) : 1149 - 1154
  • [5] Anorexia nervosa and bulimia nervosa: An appraisal
    Sharma, A
    DRUGS OF TODAY, 2001, 37 (04) : 229 - 236
  • [6] Dynamics of bulimia disorders in anorexia nervosa and bulimia nervosa
    Marilov, V. V.
    Sologub, M. B.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, 108 (01): : 18 - 22
  • [7] Dysthymia in anorexia nervosa and bulimia nervosa
    Borda-Mas, Mercedes
    Torres-Perez, Inmaculada
    del Rio-Sanchez, Carmen
    INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY, 2008, 8 (01) : 65 - 75
  • [8] Pharmacotherapy for Anorexia Nervosa and Bulimia Nervosa
    Greetfeld, M.
    Cuntz, U.
    Voderholzer, U.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2012, 80 (01) : 9 - 16
  • [9] Adiponectin in anorexia nervosa and bulimia nervosa
    Tagami, T
    Satoh, N
    Usui, T
    Yamada, K
    Shimatsu, A
    Kuzuya, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04): : 1833 - 1837
  • [10] Anorexia and bulimia nervosa
    Csef, H
    MONATSSCHRIFT KINDERHEILKUNDE, 1999, 147 (04) : 396 - 406